Koenig Sheldon L. (CIK 0001766524)

Latest company ownership

ESPR - Esperion Therapeutics, Inc.

Role: CEO

Shares held

1,518,831

Last filed at

Sep 18, 2025

Confidence Score

22.9

2025Q4

Confidence Score History

2022Q1 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Dec 17, 2025	Dec 18, 2025	Esperion Therapeutics, Inc.	CEO	Sell	22.5	-48,244	-3.18%	✗	$177.2K
Sep 17, 2025	Sep 18, 2025	Esperion Therapeutics, Inc.	CEO	Sell	22.5	-28,427	-1.84%	✗	$79.3K
Jun 17, 2025	Jun 18, 2025	Esperion Therapeutics, Inc.	CEO	Sell	26.3	-30,474	-1.94%	✗	$33.8K
Mar 18, 2025	Mar 19, 2025	Esperion Therapeutics, Inc.	CEO	Sell	36.3	-13,047	-0.82%	✗	$19.6K
Dec 17, 2024	Dec 18, 2024	Esperion Therapeutics, Inc.	CEO	Sell	26.3	-12,447	-1.65%	✗	$30.7K
Sep 17, 2024	Sep 18, 2024	Esperion Therapeutics, Inc.	CEO	Sell	26.3	-14,550	-1.90%	✗	$26.1K
May 9, 2023	May 10, 2023	Esperion Therapeutics, Inc.	CEO	Buy	86.3	+20,000	6.83%	✗	$25.2K
Mar 17, 2023	Mar 20, 2023	Esperion Therapeutics, Inc.	CEO	Sell	26.3	-6,999	-2.33%	✗	$12.5K
Mar 7, 2023	Mar 8, 2023	Esperion Therapeutics, Inc.	CEO	Sell	26.3	-5,441	-2.72%	✗	$27.5K
Sep 19, 2022	Sep 20, 2022	Esperion Therapeutics, Inc.	CEO	Sell	26.3	-3,394	-1.68%	✗	$23.5K
Aug 5, 2022	Aug 8, 2022	Esperion Therapeutics, Inc.	CEO	Buy	83.8	+8,606	4.53%	✗	$50K
Jun 17, 2022	Jun 21, 2022	Esperion Therapeutics, Inc.	CEO	Sell	26.3	-4,552	-2.34%	✗	$22.7K
Mar 17, 2022	Mar 18, 2022	Esperion Therapeutics, Inc.	CEO	Sell	45.0	-571	-0.29%	✗	$2.6K